Pharmacy Insights

Pharmacy Insights

  • Healthcare
  • Pharmacy

Blueprint poised to elevate Ayvakit to blockbuster status with rapid growth in ISM 

Oct 21, 2024
  • Healthcare
  • Pharmacy

Madrigal cultivates Rezdiffra’s foothold in MASH as GLP-1 competitors seek approval

Sep 17, 2024
  • Healthcare
  • Pharmacy

Winrevair: Potential Blockbuster in PAH

Aug 7, 2024
  • Healthcare
  • Pharmacy

Tirzepatide (Mounjaro) remains king according to GLP1+ pharmacy claims data

Jul 30, 2024
  • Healthcare
  • Pharmacy

Significant number of ex-Mounjaro patients switch to Ozempic 

Jul 22, 2024
  • Healthcare
  • Pharmacy

Barriers to GLP1 access drive higher telehealth use by patients living with obesity 

Jul 16, 2024
arrow-downarrow-leftarrow-rightcaret-down-menucaret-downcarrot-rightcheckclosefacebook-squarefilterhamburgerinstagram-squarelinkedin-squaremobile-parent-indicatorpauseplayprintertwitter-square